Ischaemic heart disease, influenza and influenza vaccination: A prospective case control study

Heart

Volumn 99, Issue 24, 2013, Pages 1843-1848

  MacIntyre, C Raina ^a,b   Heywood, Anita E ^a   Kovoor, Pramesh ^c   Ridda, Iman ^a,b   Seale, Holly ^a   Tan, Timothy ^c,d   Gao, Zhanhai ^a   Katelaris, Anthea L ^a   Siu, Ho Wai Derrick ^e   Lo, Vincent ^e   Lindley, Richard ^c   Dwyer, Dominic E ^c,f  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; INFLUENZA VACCINE;

ACUTE HEART INFARCTION; ADULT; AGED; ANTIBODY TITER; ARTICLE; AUSTRALIA; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; ETHNICITY; FEMALE; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; SELF REPORT; TERTIARY HEALTH CARE; WINTER;

CORONARY ARTERY DISEASE; INFECTION;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NEW SOUTH WALES; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; VACCINATION;

EID: 84888052805     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304320     Document Type: Article

References (33)

1. Nielsen J, Mazick A, Glismann S, et al. Excess mortality related to seasonal influenza and extreme temperatures in Denmark, 1994-2010. BMC Infect Dis 2011;11:350.
2. Chiu C, Dey A, Wang H, et al. Vaccine preventable diseases in Australia, 2005 to 2007. Commun Dis Intell 2010;34(Supp):S1-167.
3. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010;59:1-62.
4. Reichert TA, Simonsen L, Sharma A, et al. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol 2004;160:492-502.
5. Newall AT, Wood JG, Macintyre CR. In fluenza-related hospitalisation and death in Australians aged 50 years and older. Vaccine 2008;26:2135-41.
6. Tillett HE, Smith JW, Gooch CD. Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol 1983;12:344-52.
7. Warren-Gash C, Bhaskaran K, Hayward A, et al. Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong. J Infect Dis 2011;203:1710 -8.
8. Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004;351:2611-8.
9. Meier CR, Jick SS, Derby LE, et al. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 1998;351:1467-71.
10. Sydney West Area Health Service. Healthcare Services Plan 2005-2010 - CAREFirst Strategic Health Investment Priorities. In: NSW Health, ed. 2006. http://www.wsahs.nsw.gov.au/services/dsdph/StPl/PUBLICAT/SWAHS-Healthcare- Services-Plan-final-April.pdf. (accessed Oct 2012).
11. Kok J, Blyth CC, Foo H, et al. Comparison of a rapid antigen test with nucleic acid testing during cocirculation of pandemic in fluenza A/H1N1 2009 and seasonal influenza A/H3N2. J Clin Microbiol 2010;48:290-1.
12. Druce J, Tran T, Kelly H, et al. Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002-2003. J Med Virol 2005;75:122-9.
13. Last JM. A dictionary of epidemiology. 4th edn New York: Oxford University Press, 2001.
14. Torvaldsen S, McIntyre PB. Observational methods in epidemiologic assessment of vaccine effectiveness. Commun Dis Intell 2002;26:451- 7.
15. Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000;102:3039-45.
16. Guan X, Yang W, Sun X, et al. Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction. Inflamm Res 2012;61:591-8.
17. Phrommintikul A, Kuanprasert S, Wongcharoen W, et al. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J 2011;32:1730-5.
18. Hung IF, Leung AY, Chu DW, et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis 2010;51:1007-16.
19. Ciszewski A, Bilinska ZT, Brydak LB, et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J 2008;29:1350-8.
20. Gurfinkel EP, Leon de la Fuente R, Mendiz O, et al. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J 2004;25:25-31.
21. Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348:1322-32.
22. Gurfi nkel EP, de la Fuente RL, Mendiz O, et al. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 2002;105:2143-7.
23. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997;96:4095-103.
24. Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of infl uenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995;123:518-27.
25. Hampson AW, Irving LB. Infl uenza vaccination: cost-effective health care for the older adult? J Qual Clin Pract 1997;17:3-11.
26. National Health and Medical Research Council. The Australian immunisation handbook. 9th edn. Canberra: Australian Government Department of Health and Ageing, 2008.
27. Australian Institute of Health and Welfare (AIHW). 2009 Adult vaccination Survey. Summary results. Canberra: Australian Government Department of Health and Ageing, 2011. http://www.aihw.gov.au (accessed Oct 2012).
28. Newall AT, Kelly H, Harsley S, et al. Cost effectiveness of in fluenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group. Pharmacoeconomics 2009;27:439-50.
29. Begg SJ, Vos T, Barker B, et al. Burden of disease and injury in Australia in the new millennium: measuring health loss from diseases, injuries and risk factors. Med J Aust 2008;188:36-40.
30. Australian Institute of Health and Welfare (AIHW). Australia's health 2010. Canberra: Australian Government Department of Health and Ageing, 2010. http://www.aihw.gov.au (accessed Oct 2012).
31. Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifi able risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet 2004;364:937-52.
32. Fleming DM, Cross KW, Pannell RS. Influenza and its relationship to circulatory disorders. Epidemiol Infect 2005;133:255-62.
33. Warren-Gash C, Hayward AC, Hemingway H, et al. Infl uenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER Self-Controlled Case Series Study. J Infect Dis 2012;206:1652-9.